A new approach to assessing antihypertensive therapy: Effect of treatment on pulse pressure

Journal of Hypertension

Volumn 18, Issue 11, 2000, Pages 1683-1690

  Asmar, Roland ^a   Lacourciére, Yves ^b  

^a L'Institut CardioVasculaire   (France)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Ambulatory blood pressure monitoring; AT1 receptor blockers; Candesartan cilexetil; Hypertension; Losartan; Pulse pressure

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; LOSARTAN; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0033755879     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018110-00022     Document Type: Article

References (33)

1. World Health Organization-International Society of Hypertension guidelines for the management of hypertension
2. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI)
3. Non-invasive evaluation of arterial abnormalities in hypertensive patients
4. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population
5. Pulse pressure and resistance artery structure in the elderly
6. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study
7. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension
8. Pulse pressure in essential hypertension: Clinical and therapeutical implications
9. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis
10. Measures of blood pressure and myocardial infarction in treated hypertensive patients
11. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction
12. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function
13. Pulse pressure and echocardiographic findings in essential hypertension
14. Pulse pressure in sustained essential hypertension: A hemodynamic study
15. Is pulse pressure useful in predicting coronary heart disease? The Framingham Heart study
16. Pulse pressure - III. Prognostic significance in four Chicago epidemiologic studies
17. Pulsatile versus steady component of blood pressure: A cross-sectional and perspective analysis of cardiovascular mortality
18. Ambulatory pulse pressure. A potent predictor of total cardiovascular risk in hypertension
19. Ambulatory blood pressure measurement, smoking and abnormalities of glucose and lipid metabolism in essential hypertension
20. Ambulatory blood pressure profile after carotid endarterectomy in patients with ischaemic arterial disease
21. Angiotensin II receptors and angiotensin II receptor antagonists
22. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
23. A randomized, double-blind comparison of the angiotensin II receptor antagonists irbesartan with the full dose range of enalapril for the treatment of mild-to-moderate hypertension
24. Blood pressure effects of the angiotensin II receptor blocker, losartan
25. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension
26. Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect
27. Candesartan cilexetil. A review of its use in essential hypertension
28. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients. A placebo-controlled, forced titration study
29. 1-receptor blockers in isolated vessels of different origin
30. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers
31. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension
32. Factors that affect blood pressure variability. A community-based study in Ohasama, Japan
33. Arterial mechanics and wave reflection with antihypertensive therapy